弥散加权成像引导的移行区评分在移行区前列腺癌检测中的价值:与现行PI-RADS v2.1评分的比较
研究纳入40例移行区前列腺癌(TZPCa)患者和40例无TZPCa的良性前列腺增生患者,比较DWI引导的移行区评分与常规PI-RADS v2.1移行区评分。以PI-RADS≥3为阳性时,DWI引导评分特异度0.896 vs 0.542(p<.001),PPV 0.764 vs 0.439(p<.001),NPV 0.853 vs 0.759(p=.001),敏感度0.687 vs 0.676(p=.836);观察者间κ值0.584 vs 0.155(p=.003)。结论认为DWI引导的移行区评分提高了观察者间一致性、特异度和预测值,且不损害敏感度。
要点
- DWI引导的移行区评分较常规PI-RADS v2.1评分提高特异度(0.896 vs 0.542,p<.001)和PPV(0.764 vs 0.439,p<.001)。
- DWI引导的移行区评分观察者间一致性κ=0.584,高于常规评分的κ=0.155(p=.003)。
- 以PI-RADS≥4为阳性时,DWI引导评分特异度和PPV仍更高(0.986 vs 0.944,p=.007;0.943 vs 0.810,p=.009),敏感度和NPV无统计学差异。
核心结论
- DWI引导的移行区评分提高了观察者间一致性、特异度和预测值,且不损害敏感度。
研究设计与样本
- 研究纳入40例移行区前列腺癌患者和40例无移行区前列腺癌的良性前列腺增生患者,由泌尿专科放射科医师与病理科医师共识完成病灶与病理映射表的一对一对应,由另外3名放射科医师独立记录常规PI-RADS v2.1移行区评分和DWI引导的移行区评分,间隔4周。
诊断标准与关键数值
- DWI引导的移行区评分定义为先评估DWI/ADC图像识别可疑灶,再与T2加权成像对应,最后基于PI-RADS v2.1赋分。以PI-RADS≥3为阳性时,DWI引导评分与常规评分的特异度0.896 vs 0.542(p<.001)、PPV 0.764 vs 0.439(p<.001)、NPV 0.853 vs 0.759(p=.001)、敏感度0.687 vs 0.676(p=.836)。以PI-RADS≥4为阳性时,特异度0.986 vs 0.944(p=.007)、PPV 0.943 vs 0.810(p=.009),敏感度0.468 vs 0.468(p=.998)、NPV 0.785 vs 0.776(p=.537)。观察者间κ值0.584 vs 0.155(p=.003)。
临床应用与阅片要点
- 作者认为DWI引导的移行区评分可提高观察者间一致性、特异度和预测值,且不损害敏感度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To compare the performance of diffusion-weighted imaging-guided transitional zone (TZ) lesion scoring on T2-weighted imaging (DWI-guided TZ scoring) to conventional PI-RADS TZ scoring.
METHODS: Forty patients carried transition zone prostate cancer (TZPCa), and 40 patients had benign prostatic hyperplasia without TZPCa. A lesion-base, one-to-one correlation between the pathologic mapping sheet and the corresponding MR imaging was conducted by consensus between the genitourinary-specialized radiologist and pathologist. DWI-guided TZ scoring was defined as evaluating the DWI/apparent diffusion coefficient (ADC) images first, identifying the suspicious foci, then correlating the foci with the T2-weighted imaging, and finally assigning the PI-RADS score based on PI-RADS v2.1. Three other radiologists independently recorded the PI-RADS v2.1 scoring for TZ and the DWI-guided TZ scoring, with a time interval of 4 weeks.
RESULTS: When a PI-RADS score of ≥ 3 was considered a positive lesion, the specificity, PPV, NPV and sensitivity between the DWI-guided TZ scoring and conventional PI-RADS TZ scoring were 0.896 vs. 0.542 (p < .001), 0.764 vs. 0.439 (p < .001), 0.853 vs. 0.759 (p = .001), and 0.687 vs. 0.676 (p = .836), respectively. When PI-RADS scores ≥ 4 was considered cancer-positive, the specificity and PPV were also higher when applying DWI-guided TZ scoring (0.986 vs. 0.944, p = .007; 0.943 vs. 0.810, p = .009, respectively); however, the sensitivity and NPV were not statistically different (0.468 vs. 0.468, p = .998; 0.785 vs. 0.776, p = .537, respectively). The interobserver agreement presented as κ-value was higher in DWI-guided TZ scoring (0.584) than in conventional PI-RADS TZ scoring (0.155) (p = .003).
CONCLUSIONS: DWI-guided TZ scoring improves the interobserver agreement, specificity, and predictive value without impairing the sensitivity.
引用
- Lee MS, Park JH, Kim SY, et al. Diffusion weighted image-guided transitional zone scoring in the detection of transitional zone prostate cancer: comparison with current PI-RADS v2.1 scoring. Abdom Radiol (NY). 2024. PMID: 39354237. doi:10.1007/s00261-024-04615-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。